Categories AlphaGraphs, Earnings, Other Industries
Strong Q4 earnings send General Motors stock northwards
General Motors (GM) Wednesday reported fourth-quarter adjusted earnings of $1.43 per share, much higher than $1.21 per share projected by analysts, driven by strong pricing and surging crossover sales, successful execution of the company’s full-size truck launch.
Revenue grew 1.8% to $38.4 billion during the fourth quarter. Analysts had expected the top line to hit just $37 billion.
Buoyed by the results, GM shares jumped 4.2% during pre-market trading. The stock has lost 6% of its value in the past 12 months.
On a reported basis, the company swung to earnings of $1.40 per share from a loss of $3.56 per share a year ago.
CFO Dhivya Suryadevara said, “We navigated significant headwinds in 2018 to deliver another year of strong results, demonstrating the earnings resiliency of this company. The actions we’ve been taking to shape a stronger, more profitable portfolio of businesses position GM for long-term success
General Motors is currently going through a transitional phase as it shifts its focus towards pickups, a segment that is more profitable than cars. The company, which is struggling in the cut-throat competition in the auto market, is reportedly in the process of laying off around 4,000 employees.
The auto-giant had last week announced that it was negotiating the “feasibility” of investing about $2.73 billion (10 billion reais) in Brazil for a span of four years — from 2020 to 2024.
LISTEN TO: GENERAL MOTORS Q4 2018 EARNINGS CONFERENCE CALL
This declaration comes just a month after the company said it would only consider new investments depending on its ability to return to profit.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference, and much more!
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company